LivaNova
LIVN
218 hedge funds and large institutions have $3B invested in LivaNova in 2022 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 100 increasing their positions, 61 reducing their positions, and 23 closing their positions.
64% more repeat investments, than reductions
Existing positions increased: 100 | Existing positions reduced: 61
39% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 23
35% more call options, than puts
Call options by funds: $26.9M | Put options by funds: $19.9M
7% more capital invested
Capital invested by funds: $2.81B → $3B (+$193M)
3% more funds holding
Funds holding: 212 → 218 (+6)
2.37% less ownership
Funds ownership: 103.2% → 100.83% (-2.4%)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$73.7M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$22.9M |
| 3 |
BlackRock
New York
|
+$21.4M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$20.8M |
| 5 |
JFG
Jefferies Financial Group
New York
|
+$15.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Harris Associates
Chicago,
Illinois
|
-$80.8M |
| 2 |
SHCM
Sachem Head Capital Management
New York
|
-$69M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$22M |
| 4 |
EC
Eminence Capital
New York
|
-$18M |
| 5 |
HM
HealthCor Management
New York
|
-$16.7M |
LIVN Hedge Fund Activity: Q4 2022 in Review
218 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in LivaNova (LIVN) for Q4 2022, worth a combined $3B — up 6.9% from $2.81B a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new LIVN positions and 23 closed out — a net gain of 9 holders — while 100 added to existing stakes and 61 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $73.7M. The largest seller was Harris Associates, cutting an estimated $80.8M.
- 218 institutional investors held LivaNova (LIVN) as of Q4 2022, up from 212 in Q3 2022.
- Funds reported $3B of LivaNova stock for Q4 2022, up 6.9% quarter-over-quarter.
- 32 funds opened new LivaNova positions in Q4 2022 and 23 closed out, a net change of +9 holders.
- The largest LivaNova buyer in Q4 2022 was Morgan Stanley, an estimated $73.7M added.
- The largest LivaNova seller in Q4 2022 was Harris Associates, an estimated $80.8M sold.
Based on aggregated 13F filings for Q4 2022.